http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2336061-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb302b4b271201a200dbd4d1a7ab0b2e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate | 2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40892305216361fe2a9d017de0c3edb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d5e9e9f50f2d60046553327d4c32b80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d8634608f6c5f093b147ef2bdc2675 |
| publicationDate | 2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2336061-C1 |
| titleOfInvention | Method of cytostatic therapy for prevention of excess scarring resulted from penetrating antiglaucomatous surgery |
| abstract | FIELD: medicine; ophthalmology. n SUBSTANCE: cytostatic agent is subconjuctive introduced. Agent introduced is added with 0.08% trypan blue solution in amount 0.05 ml. Introduced agent localisation is visualised. In case agent becomes localized in anterior chamber or escapes through conjunctive suture introduction is stopped. In case agent spreads under conjunctiva dose in required amount is introduced. n EFFECT: lower rate of complications caused by cytostatics introduction. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2465872-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2680210-C2 |
| priorityDate | 2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.